InMode (INMD) EBT Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.82% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 32.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.06% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.57% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 14.40% |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | -31.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.31% |
| Dec 31, 2025 | -21.16% |
| Sep 30, 2025 | -21.98% |
| Jun 30, 2025 | -13.78% |
| Mar 31, 2025 | -14.04% |
| Dec 31, 2024 | -15.96% |
| Sep 30, 2024 | 8.98% |
| Jun 30, 2024 | -13.67% |
| Mar 31, 2024 | -0.93% |
| Dec 31, 2023 | 17.95% |
| Sep 30, 2023 | 24.69% |
| Jun 30, 2023 | 90.04% |
| Mar 31, 2023 | 51.71% |
| Dec 31, 2022 | 48.51% |
| Sep 30, 2022 | 47.39% |
| Jun 30, 2022 | 42.97% |
| Mar 31, 2022 | 50.72% |
| Dec 31, 2021 | 303.52% |
| Sep 30, 2021 | 72.16% |
| Jun 30, 2021 | 75.43% |